SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $34,000 | -96.5% | 200 | -97.6% | 0.00% | -100.0% |
| Q1 2020 | $971,000 | -95.6% | 8,420 | -95.7% | 0.00% | -94.8% |
| Q4 2019 | $22,226,000 | +116878.9% | 194,519 | +69371.1% | 0.08% | – |
| Q2 2019 | $19,000 | -78.2% | 280 | -76.4% | 0.00% | – |
| Q1 2019 | $87,000 | -93.9% | 1,184 | -95.6% | 0.00% | -100.0% |
| Q4 2016 | $1,418,000 | -10.1% | 26,872 | -8.0% | 0.01% | -30.0% |
| Q3 2016 | $1,578,000 | +245.3% | 29,216 | +158.9% | 0.02% | +185.7% |
| Q2 2016 | $457,000 | – | 11,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |